Showing results (81-90 of 65,891) with videos related to
Sort By:
Pageof 6,590
Current Opinion in Pharmacology|May 4, 2012
Treatment of COPD: moving beyond the lungsM Gabriella Matera, Luigino Calzetta, Barbara Rinaldi, et al.Therapeutic Advances in Drug Safety|February 17, 2017
Tiotropium formulations and safety: a network meta-analysisMario Cazzola, Luigino Calzetta, Paola Rogliani, et al.Pulmonary Pharmacology & Therapeutics|February 10, 2015
Canakinumab for the treatment of chronic obstructive pulmonary diseasePaola Rogliani, Luigino Calzetta, Josuel Ora, et al.Minerva Medica|February 9, 2022
The interplay between diabetes mellitus and chronic obstructive pulmonary diseaseAnnalisa Frizzelli, Marina Aiello, Luigino Calzetta, et al.Expert Opinion on Drug Metabolism & Toxicology|December 4, 2013
Use of indacaterol for the treatment of COPD: a pharmacokinetic evaluationMario Cazzola, Luigino Calzetta, Clive P Page, et al.Journal of Experimental Pharmacology|December 16, 2020
Long-Acting Muscarinic Antagonists Under Investigational to Treat Chronic Obstructive Pulmonary DiseaseJosuel Ora, Angelo Coppola, Mario Cazzola, et al.Expert Opinion on Drug Delivery|June 21, 2023
Delivering monoclonal antibodies via inhalation: a systematic review of clinical trials in asthma and COPDRossella Laitano, Luigino Calzetta, Francesco Cavalli, et al.Journal of Clinical Medicine|August 12, 2022
Comparing the Efficacy and Safety Profile of Triple Fixed-Dose Combinations in COPD: A Meta-Analysis and IBiS ScorePaola Rogliani, Josuel Ora, Francesco Cavalli, et al.Forensic Science International|January 11, 2005
Third mandibular molar radiological development as an indicator of chronological age in a European populationAlessandra De Salvia, Corinne Calzetta, Marco Orrico, et al.International Journal of Chronic Obstructive Pulmonary Disease|December 31, 2014
The clinical use of regenerative therapy in COPDRoberto Lipsi, Paola Rogliani, Luigino Calzetta, et al.Pageof 6,590